Incidence and Survival of Hemophagocytic Lymphohistiocytosis Over Two Decades: A Population‐Based Study
European Journal of Haematology · 2026
DOI: 10.1111/ejh.70181 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift European Journal of Haematology, 2026. Verfasst von Mads Okkels Birk Lorenzen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Aarhus University Hospital, Aarhus, Denmark. Hauptthemen laut MEDLINE: Lymphohistiocytosis, Hemophagocytic, Population Surveillance. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Danish Cancer Society Research Center, Danmarks Frie Forskningsfond, North Jutland Region Research Fund.
Abstract (Originalsprache)
Adult hemophagocytic lymphohistiocytosis (HLH) is a rare, life‐threatening syndrome triggered by various conditions. A nationwide study of the incidence and outcomes of HLH in Denmark over 23 years (2000–2023) was performed. Adults (≥ 18 years) with HLH and triggering diseases were identified in the Danish National Patient Registry and/or the Danish Pathology Registry. A total of 325 cases were identified. The incidence increased from 0.82 per 1 million person‐years (1 M‐PY) (95% CI 0.61–1.04) in 2000–2011 to 4.05 per 1 M‐PY (95% CI 3.56–4.53) in 2012–2023. Hematologic malignancies were the triggering diagnosis in 46% of cases, mostly lymphomas (32%). There was no clear improvement in overall survival over time. However, survival differed markedly between subgroups, with the lowest 1‐year overall survival of 31% for hematologic malignancy–associated HLH, compared with 75% for idiopathic HLH. In conclusion, HLH remains a rare syndrome with a dismal prognosis, especially when associated with hematologic malignancy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hematology, Aarhus University Hospital, Aarhus, Denmark.
- Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.
- Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
- Department of Hematology, Clinical Cancer Research Centre, Aalborg University Hospital, Aalborg, Denmark.
- Unit of Research Data and Biostatistics, Faculty of Medicine, Aalborg University Hospital, Aalborg, Denmark.
- Center for Clinical Data Science, Aalborg University, Aalborg, Denmark.
ORCID-Profile: Mads Okkels Birk Lorenzen, Martin Jensen, Rasmus Rask Kragh Jørgensen, Paw Jensen, Dennis L Hansen, Daniel El Fassi
Förderung
- Danish Cancer Society Research Center
- Danmarks Frie Forskningsfond
- North Jutland Region Research Fund
Zitieren
APA
Lorenzen, M. O. B., Jensen, M., Jørgensen, R. R. K., Jensen, P., Frederiksen, H., Hansen, D. L., El Fassi, D., Andersen, M. N., & El-Galaly, T. C. (2026). Incidence and Survival of Hemophagocytic Lymphohistiocytosis Over Two Decades: A Population‐Based Study. European Journal of Haematology. https://doi.org/10.1111/ejh.70181
Vancouver
Lorenzen MOB, Jensen M, Jørgensen RRK, Jensen P, Frederiksen H, Hansen DL, et al. Incidence and Survival of Hemophagocytic Lymphohistiocytosis Over Two Decades: A Population‐Based Study. European Journal of Haematology. 2026. doi:10.1111/ejh.70181
BibTeX
@article{Lorenzen2026,
author = {Lorenzen, Mads Okkels Birk and Jensen, Martin and Jørgensen, Rasmus Rask Kragh and Jensen, Paw and Frederiksen, Henrik and Hansen, Dennis L and El Fassi, Daniel and Andersen, Morten Nørgaard and El-Galaly, Tarec Christoffer},
title = {Incidence and Survival of Hemophagocytic Lymphohistiocytosis Over Two Decades: A Population‐Based Study},
journal = {European Journal of Haematology},
year = {2026},
doi = {10.1111/ejh.70181}
}
EUVIMED